Page last updated: 2024-11-02

orphenadrine and Vertigo

orphenadrine has been researched along with Vertigo in 3 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HAVINGA, H1
Camarda, V1
Di Carlo, A1
Marchiori, C1
Russolo, M1

Trials

1 trial available for orphenadrine and Vertigo

ArticleYear
A controlled study of the effect of orphenadrine hydrochloride (Disipal) on vertigo in patients with spontaneous vestibular disease.
    The British journal of clinical practice, 1982, Volume: 36, Issue:5

    Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Labyrinth Diseases; Orphenadrine; Vertigo; Ve

1982

Other Studies

2 other studies available for orphenadrine and Vertigo

ArticleYear
[Treatment of posttraumatic dizziness with disipal].
    Nederlands militair geneeskundig tijdschrift, 1958, Volume: 11, Issue:7

    Topics: Craniocerebral Trauma; Diphenhydramine; Dizziness; Humans; Orphenadrine; Vertigo

1958
[Data on the use of orphenadrine in the medical treatment of vertiginpus syndromes].
    Minerva medica, 1969, Feb-14, Volume: 60, Issue:13

    Topics: Humans; Labyrinth Diseases; Neurilemmoma; Neuritis; Orphenadrine; Vertigo; Vestibulocochlear Nerve

1969